| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.076 | 0.08 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.09 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.086 | 0.09 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |